Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

XERS holding history

Xeris Biopharma Holdings, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XERS overviewAll 13F holders of XERSFull Q2 2026 holdings

Shares (Q2 2026)
7,804,758
Value
$61.8M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of XERS by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,804,758$61.8M<0.1%+15,947+0.2%AddedHolders
Q1 20267,788,811$45.2M<0.1%+213,961+2.8%AddedHolders
Q4 20257,574,850$59.5M<0.1%+1,734,964+29.7%AddedHolders
Q3 20255,839,886$47.5M<0.1%+2,004,479+52.3%AddedHolders
Q2 20253,835,407$17.9M<0.1%+783,035+25.7%AddedHolders
Q1 20253,052,372$16.8M<0.1%+1,688,920+123.9%AddedHolders
Q4 20241,363,452$4.62M<0.1%+378,437+38.4%AddedHolders
Q3 2024985,015$2.81M<0.1%+466,991+90.1%AddedHolders
Q2 2024518,024$1.17M<0.1%−188,987−26.7%ReducedHolders
Q1 2024707,011$1.56M<0.1%−347,599−33.0%ReducedHolders
Q4 20231,054,610$2.48M<0.1%+179,200+20.5%AddedHolders
Q3 2023875,410$1.63M<0.1%+149,359+20.6%AddedHolders
Q2 2023726,051$1.90M<0.1%+593,872+449.3%AddedHolders
Q1 2023132,179$215.5K<0.1%−30,200−18.6%ReducedHolders
Q4 2022162,379$216.0K<0.1%+5,124+3.3%AddedHolders
Q3 2022157,255$245.0K<0.1%+108,392+221.8%AddedHolders
Q2 202248,863$75.0K<0.1%−100,183−67.2%ReducedHolders
Q1 2022149,046$382.0K<0.1%+149,046NewHolders
Q3 20210$00.0%−261,488−100.0%Sold outHolders
Q2 2021261,488$1.06M<0.1%−723,828−73.5%ReducedHolders
Q1 2021985,316$4.44M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.